We demonstrated an elevation of IL-6 and IL-18 mRNA and protein in serum and urine from T2DM patients, which supports the use of cytokines as markers reflecting the acceleration of microinflammation [9–11]. This evidence concerns the gene IL18 and type 2 diabetes mellitus.